Your best medicine news resource
May 15th 2008Drug InformationCancer
Experts in treating a rare group of cancers that affect tissues such as muscle, fat, nerves and the gastrointestinal wall are meeting in Milan, Italy on 13-14 May to discuss the latest information on how these diseases develop and potential new avenues for therapy.
More: continued here
May 15th 2008Drug InformationCancer
Cancers will be much more effectively treated when physicians can determine all of the responsible genetic changes in a tumor and how they react and interact in response to specific treatment(s), according to one of the leading scientists who will be speaking at the BIO 2008 International Convention. On Tuesday, June 17 in a session titled, “Genomics Drives Disruptive Innovations in Biotechnology,” Lynda Chin, M.D.
More: continued here
May 15th 2008Drug InformationCancer
Studying thousands of patients, Japanese researchers have found a strong link between tooth loss and increased risk of three cancers esophageal, head and neck, and lung. They suggest that preservation of teeth may decrease risk of developing these diseases.
More: continued here
May 15th 2008Drug InformationCancer
A team of medical researchers led by Dr Ruth Kluck at Melbourne’s Walter and Eliza Hall Institute (WEHI) has discovered a key step in the mechanism by which cells destroy themselves. In this process, called “apoptosis”, certain proteins cause the cell to self-destruct by puncturing its “power plant.” How the proteins do this has been clarified by the WEHI team. The discovery is an important step towards the identification of targets for drugs designed to regulate cell death.
More: continued here
May 15th 2008Drug InformationCancer
Cancer Research UK has this week celebrated its inaugural Business Supporters’ Awards, in celebration of the contribution made by business to help the charity beat cancer. The event, held on Tuesday 6th May at the Royal College of Surgeons, London, brought together the charity’s biggest supporters from the world of business to recognise the very best in business and charity partnerships and to inspire future relationships.
More: continued here
May 15th 2008Drug InformationCancer
Chances are you or someone you know has had laser eye surgery to correct blurry vision. Now, doctors are using the procedure in a new way. In some cases, they’re not just helping patients see better, they’re actually preventing them from going blind. Mike Samogala says he’s never taken time with his kids for granted. Lately, those moments have meant even more. Just a few months ago, Mike was diagnosed with eye cancer. It came with no warning or symptoms.
More: continued here
May 15th 2008Drug InformationCancer
Survivors of childhood cancers treated with the chemotherapy drug cyclophosphamide were five times more likely to develop bladder cancer later in life than the general population. Results of this new research from the United Kingdom were presented during the Annual Scientific Meeting of the American Urological Association (AUA).
More: continued here
May 15th 2008Drug InformationCancer
Stem cells - popularly known as a source of biological rejuvenation - may play harmful roles in the body, specifically in the growth and spread of cancer. Amongst the wildly dividing cells of a tumor, scientists have located cancer stem cells. Physician-scientists from New York-Presbyterian/Weill Cornell are studying these cells with the hope of combating malignant cancers in the brain. Some patients’ brain tumors respond to chemotherapy and some don’t, according to Dr. John A.
More: continued here
May 15th 2008Drug InformationCancer
“In some communities, death rates” from cancer are “substantially higher than in others,” and the rates are “shamefully high among minorities and the poor because many lack access to lifesaving prevention and treatment measures,” Lance Armstrong, a cyclist and testicular cancer survivor, writes in a Wall Street Journal opinion piece. “On many levels, we know how to defeat cancer; we just don’t do it,” according to Armstrong.
More: continued here
May 15th 2008Drug InformationCancer
The Institute of Cancer Research is delighted to announce the appointment of eminent molecular pathologist Dr George Thomas as head of the newly-created Translational Molecular Oncology Team. In his new position Dr Thomas will play a major role in The Institute’s targeted drug discovery programme, with a particular focus on prostate and kidney cancers.
More: continued here
Your best medicine news resource
